Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on September 24, 2025
Larry Anderson Joins Purple Crayon Brand as Co-Chair Advisory Board and EVP
Larry Anderson joins Purple Crayon Brand as Co-Chair Advisory Board and EVP. Purple Crayon Brand to expand offering to MedTech, Healthcare and PE’s and VC’s NEW YORK, NY, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- Purple Crayon Brand Names …
New Children’s Book `A Story of Molecular Crime` Brings Brain Science to Life with Action, Humor, and Heart
Neuroscience and storytelling unite in a STEM-focused children’s book meant to inspire curiosity about the human brain. NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- A new children’s book that merges science education with thrilling …
WelcomeWare and Raintree Systems Partner to Transform Front Desk Operations in Physical Therapy Practices
WelcomeWare and Raintree Systems Partner to Enhance Self Check-In Kiosk with Live Agent Support Integrated with Raintree EMR for Physical Therapy Practices NEW YORK, NY, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- WelcomeWare®, a leader in …
Dr. David Samadi Highlights the Benefits of Robotic Surgery During September Prostate Cancer Awareness Month
Dr. David Samadi Emphasizes Robotic Surgery as the Superior Treatment for Precision, Recovery, and Quality of Life NEW YORK CITY, NY, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- September is Prostate Cancer Awareness Month, dedicated to …
NOTICE TO CUSTOMERS OF BROKERS JOHN SHORTAL, BOB VANCE, AND MOLONEY WHO PURCHASED GWG AND ALTERNATIVE INVESTMENTS
Contact the Law Firm of KlaymanToskes for a Free and Confidential Consultation to Discuss Pursuing a Potential Recovery of Your Losses NEW YORK, NY, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- National investment loss and securities law firm …
GuardDog AI Collaborates with Red Hat to Deliver Enhanced Cybersecurity for RHEL and OpenShift with UBI-Certified Sensor
New GuardDog Complete Agentic AI Sensor Provides Red Hat Enterprise Linux and OpenShift Users with a UBI-Certified Solution for Cybersecurity Attack Automation NEW YORK CITY, NY, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- GuardDog AI, Inc., …
Range Impact Announces $550,000 Capital Raise
Cleveland, Ohio, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, announced the closing of …
Verano to Report Third Quarter 2025 Financial Results on October 29, 2025
CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the third quarter ended …
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a …
Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025
GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that …
uniQure Announces $200 Million Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced a $200 million …
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
GAITHERSBURG, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In recognition of several observances in September meant to keep the national opioid poisoning epidemic front and center, Emergent BioSolutions Inc. (NYSE: EBS) today recommitted to its leadership …
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its …
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
IRVINE, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steve Perrin, Ph.D., President and Chief Scientific Officer, will participate in a plenary session at the upcoming 18th Congress …
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced a proposed underwritten public offering of shares of its Class A common stock …
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
NEW HAVEN, Conn., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ: IVVD) today announced the appointment of Paul B. Bolno, M.D., to its Board of Directors and as a member of the Compensation Committee. Dr. Bolno is the President and CEO of Wave …
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
- 86% overall survival (OS) observed at 9 months; standard of care benchmark is ~47% - - 53% progression-free survival (PFS) observed at 9 months; standard of care benchmark is ~29% - - Company expects regulatory feedback on pivotal trial plans in Q4 2025 …
Inventiva to Host Analyst and Investor Event on October 8, 2025
Program will include an update on the Company’s lead asset, lanifibranor, ahead of anticipated Phase 3 NATiV3 topline results in the second half of 2026 Three renowned international experts and a patient representative will highlight key trends shaping the …
Inventiva organise un événement analystes et investisseurs le 8 octobre 2025
Le programme inclura une mise à jour sur son médicament candidat, lanifibranor, en amont des résultats principaux de l’étude de Phase 3 NATiV3 attendus au second semestre 2026 Trois experts internationaux de renom et un représentant des patients mettront …
SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen
LOS ANGELES, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) today announced that two of Southern California’s most accomplished life sciences executives -- Murthy Simhambhatla, PhD, President …